Beyond The Numbers: 4 Analysts Discuss Gritstone Bio Stock
Beyond The Numbers: 4 Analysts Discuss Gritstone Bio Stock
超越數字：4位分析師討論Gritstone Bio股票
In the latest quarter, 4 analysts provided ratings for Gritstone Bio (NASDAQ:GRTS), showcasing a mix of bullish and bearish perspectives.
在最近一個季度中，4位分析師爲Gritstone Bio（納斯達克股票代碼：GRTS）提供了評級，顯示了看漲和看跌的觀點。
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
下表簡要概述了他們最近的評級，重點介紹了過去30天中情緒的變化，並將其與前幾個月進行了比較。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $5.0, with a high estimate of $7.00 and a low estimate of $4.00. A decline of 9.09% from the prior average price target is evident in the current average.
分析師對12個月目標股價的評估提供了更多見解，顯示平均目標價爲5.0美元，最高估計爲7.00美元，低估值爲4.00美元。目前的平均價格比先前的平均目標股價下降了9.09％。
Diving into Analyst Ratings: An In-Depth Exploration
深入分析師評級：深度探索
The standing of Gritstone Bio among financial...
通過對分析師近...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。